In a case of acute myeloid leukemia (AML), METTL3 can be recruited to the promoter region independent of METTL14 by binding to CCAAT/enhancer-binding protein zeta (CEBPZ)18. The gene discussed is METTL3; the disease is acute myeloid leukemia.